Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

The role of oral contraception use in the occurrence of breast cancer. A retrospective study of 405 patients.

Iatrakis G, Iavazzo C, Zervoudis S, Koumousidis A, Sofoudis C, Kalampokas T, Salakos N.

Clin Exp Obstet Gynecol. 2011;38(3):225-7.

PMID:
21995151
[PubMed - indexed for MEDLINE]
2.

Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis.

Iodice S, Barile M, Rotmensz N, Feroce I, Bonanni B, Radice P, Bernard L, Maisonneuve P, Gandini S.

Eur J Cancer. 2010 Aug;46(12):2275-84. doi: 10.1016/j.ejca.2010.04.018. Epub 2010 May 27. Review.

PMID:
20537530
[PubMed - indexed for MEDLINE]
3.

Risks of oral contraceptive use in women over 35.

Stenchever MA.

J Reprod Med. 1993 Dec;38(12 Suppl):1030-5. Review.

PMID:
8120860
[PubMed - indexed for MEDLINE]
4.

Oral contraceptives and breast cancer.

Schlesselman JJ.

Am J Obstet Gynecol. 1990 Oct;163(4 Pt 2):1379-87. Review.

PMID:
2220962
[PubMed - indexed for MEDLINE]
5.

BRCA1 and BRCA2 germ-line mutations and oral contraceptives: to use or not to use.

Grenader T, Peretz T, Lifchitz M, Shavit L.

Breast. 2005 Aug;14(4):264-8. Review.

PMID:
16085232
[PubMed - indexed for MEDLINE]
6.

Cancer of the breast and reproductive tract in relation to use of oral contraceptives.

Schlesselman JJ.

Contraception. 1989 Jul;40(1):1-38. Review.

PMID:
2673658
[PubMed - indexed for MEDLINE]
7.

Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy.

Gadducci A, Biglia N, Cosio S, Sismondi P, Genazzani AR.

Gynecol Endocrinol. 2010 Aug;26(8):568-77. doi: 10.3109/09513590.2010.487609. Review.

PMID:
20632911
[PubMed - indexed for MEDLINE]
8.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
[PubMed - indexed for MEDLINE]
9.

Weighing the evidence on the pill and breast cancer.

Johnson JH.

Fam Plann Perspect. 1989 Mar-Apr;21(2):89-92. Review.

PMID:
2653859
[PubMed - indexed for MEDLINE]
10.

Neoplasia and hormonal contraception.

Huggins GR.

Clin Obstet Gynecol. 1981 Sep;24(3):903-25. Review.

PMID:
7026111
[PubMed - indexed for MEDLINE]
11.

Epidemiology of breast cancer among BRCA mutation carriers: an overview.

Nkondjock A, Ghadirian P.

Cancer Lett. 2004 Mar 8;205(1):1-8. Review.

PMID:
15040392
[PubMed - indexed for MEDLINE]
12.

Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention.

S√łgaard M, Kjaer SK, Gayther S.

Acta Obstet Gynecol Scand. 2006;85(1):93-105. Review.

PMID:
16521688
[PubMed - indexed for MEDLINE]
13.

Oral contraceptives and gynecologic cancer: an update for the 1990s.

Kaunitz AM.

Am J Obstet Gynecol. 1992 Oct;167(4 Pt 2):1171-6. Review.

PMID:
1415442
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk